Highline Wealth Partners’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$30.2K Buy
472
+429
+998% +$28.2K 0.01% 315
2026
Q1
$3.06K Sell
43
-36
-46% -$2.84K ﹤0.01% 888
2025
Q4
$6.48K Buy
79
+44
+126% +$3.43K ﹤0.01% 493
2025
Q3
$2.63K Hold
35
﹤0.01% 799
2025
Q2
$2.59K Buy
35
+8
+30% +$557 ﹤0.01% 594
2025
Q1
$2.18K Buy
27
+7
+35% +$602 ﹤0.01% 612
2024
Q4
$1.56K Sell
20
-6
-23% -$510 ﹤0.01% 483
2024
Q3
$2.44K Buy
26
+6
+30% +$504 ﹤0.01% 435
2024
Q2
$1.56K Hold
20
﹤0.01% 423
2024
Q1
$1.82K Hold
20
﹤0.01% 338
2023
Q4
$1.55K Hold
20
﹤0.01% 318
2023
Q3
$1.36K Hold
20
﹤0.01% 293
2023
Q2
$1.63K Hold
20
﹤0.01% 242
2023
Q1
$1.64K Buy
+20
New +$1.43K ﹤0.01% 242

Other funds holding GEHC

Highline Wealth Partners's GEHC Position: Q2 2026 in Review

Highline Wealth Partners increased its GE HealthCare (GEHC) stake by 998% in Q2 2026, buying an estimated $28.2K and bringing the position to 472 shares worth $30.2K. The position accounts for 0.01% of the portfolio, ranked #315.

Highline Wealth Partners first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. 239 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Highline Wealth Partners held 472 shares of GE HealthCare worth $30.2K as of Q2 2026.
  • Highline Wealth Partners bought 429 GE HealthCare shares in Q2 2026, an estimated $28.2K.
  • GE HealthCare made up 0.01% of Highline Wealth Partners's portfolio in Q2 2026, its #315 holding.
  • Highline Wealth Partners first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • 239 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Highline Wealth Partners's 13F filing for Q2 2026, filed 15 Jul 2026.